Citation Impact
Citing Papers
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
2016 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Activation of Atypical Protein Kinase C ζ by Caspase Processing and Degradation by the Ubiquitin-Proteasome System
2000 StandoutNobel
Contribution of platelets to tumour metastasis
2011 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Triggering and modulation of apoptosis by oxidative stress
2000 Standout
Disgust as a disease-avoidance mechanism.
2009 Standout
Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi
2000
Molecular Aspects of Pancreatic Cancer and Future Perspectives
1999
Malignant Effusive Disease of the Pleura and Pericardium
1997
Rentabilidad del estudio citológico del líquido pleural en el derrame maligno
2008
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Anticipatory nausea and vomiting due to chemotherapy
2013
Coincidence, coevolution, or causation? DNA content, cell size, and the C-value enigma
2001 Standout
Efficacy of high‐dose methylprednisolone as a first‐line therapy in adult patients with idiopathic thrombocytopenic purpura
1998
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Potential mechanisms of metabolic imprinting that lead to chronic disease
1999
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Pavlovian conditioning of immune function: animal investigation and the challenge of human application
2000
Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: Matched case-control study, pathological analysis, and pathogenetic hypothesis
1997
Management of malignant pleural effusions
2001 Standout
Genome profiling of pancreatic adenocarcinoma
2011
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
The continuing problem of post chemotherapy nausea and vomiting: Contributions of classical conditioning
2006
Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival
1993
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
The Hallmarks of Aging
2013 Standout
The Causes and Consequences of Polyploidy in Normal Development and Cancer
2011
Induction of apoptosis in human mitogen‐activated peripheral blood T‐lymphocytes by the ether phospholipid ET‐18‐OCH 3 : Involvement of the Fas receptor/ligand system
1999
The inflammatory reflex
2002 StandoutNature
Anticipatory nausea and vomiting in the era of 5-HT 3 antiemetics
1998
Hypoxia-Inducible Factor 1 Regulates Vascular Endothelial Growth Factor Expression in Human Pancreatic Cancer
2003 StandoutNobel
A Critical Review on Chagas Disease Chemotherapy
2002 Standout
Antioxidant Capacity As Influenced by Total Phenolic and Anthocyanin Content, Maturity, and Variety ofVacciniumSpecies
1998 Standout
Comparison of Needle Biopsy With Cytologic Analysis for the Evaluation of Pleural Effusion: Analysis of 414 Cases
1985
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
2014
Compensation for a bad start: grow now, pay later?
2001 Standout
The potential for isoenzyme‐selective modulation of protein kinase C
1997
Acquired Platelet Dysfunction in Patients with Uremia
1990
Pleural Effusion
2002 Standout
Polyploidy in differentiation and evolution
1990
Cytologic detection of malignancy in pleural effusion: A review of 5,255 samples from 3,811 patients
1987
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
The Platelet Count in Carcinoma of the Lung and Colon
1990
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
2001
Works of M. Winkelmann being referenced
Blind pleural biopsy in combination with cytology of pleural effusions.
1981
Serum deoxythymidine kinase in myelodysplastic syndromes
1994
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia
1994
Anticipatory nausea in cancer patients receiving chemotherapy: Classical conditioning etiology and therapeutical implications
1993
Treatment results of the thioether lipid ilmofosine in patients with malignant tumours
1992
A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer
1991
Significance of polyploidy in megakaryocytes and other cells in health and tumor disease
1987
Therapie der chronischen idiopathischen thrombozytopenischen Purpura
2008
Is lower ploidy of megakaryocytes another reason for uremic thrombocytopathy?
1986
Ploidy Pattern of Megakaryocytes in Patients with Metastatic Tumors with and without Paraneoplastic Thrombosis and in Controls
1984